二氯甲烷市場 - COVID-19 的增長、趨勢、影響和預測 (2023-2028)
市場調查報告書
商品編碼
1273400

二氯甲烷市場 - COVID-19 的增長、趨勢、影響和預測 (2023-2028)

Methylene Chloride Market - Growth, Trends, and Forecasts (2023 - 2028)

出版日期: | 出版商: Mordor Intelligence | 英文 120 Pages | 商品交期: 2-3個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

在預測期內,全球二氯甲烷市場預計將以超過 4% 的複合年增長率增長。

由於油漆和塗料行業的需求不斷增長,預計該市場將會擴大。

主要亮點

  • 油漆和塗料行業不斷增長的需求預計將推動市場增長。
  • 但是,二氯甲烷有毒,在多個國家/地區受到管制。
  • 二氯甲烷在製冷劑市場已經成熟,預計未來幾年仍將保持需求。
  • 亞太地區主導市場,預計在預測期內將繼續保持這一勢頭。

二氯甲烷市場趨勢

製藥行業的需求增加

  • 二氯甲烷,也稱為二氯甲烷 (DCM),在製藥應用中用作溶劑,主要用於提取多種化合物以及生產抗生素和維生素。 也用作片劑的包衣劑。
  • 在經歷了全球製藥行業動蕩的一年之後,該行業的基本業績和前景良好。 儘管 COVID-19 藥物促進了許多公司的發展,但許多其他公司仍然相對不受大流行的某些影響。
  • 定期開發、批准和銷售新藥,導致市場顯著增長。 其他市場驅動因素包括人口老齡化,因為老年人人均使用更多的藥物,以及慢性病患病率和治療的增加。 大多數國家的人口都在老齡化。 根據世界衛生組織 (WHO) 的數據,到 2030 年,六分之一的人將超過 60 歲。
  • 到 2025 年,製藥行業預計將達到約 1.7 萬億美元,年增長率為 8%。
  • 這是由於美國、中國和印度等國家/地區的中產階級不斷壯大、人口老齡化、收入增加以及城市化進程加快所致。
  • 美國的醫療保健行業是該國最先進的行業之一。 據藥物研究與製造商協會(PhRMA)稱,美國公司研發了世界上一半以上的藥物,並擁有大多數新藥的知識產權。
  • 因此,預計製藥行業的增長將在預測期內推動對二氯甲烷的需求。
二氯甲烷市場-IMG1

亞太地區主導市場

  • 預計在預測期內,亞太地區將成為最大的二氯甲烷市場。
  • 預計中國、印度和日本等主要新興國家/地區的需求會增加。
  • 該地區對油漆和塗料的需求正在增加。 汽車和建築行業在油漆和塗料的消費中佔有很大份額。
  • 亞太地區包含世界上最重要的建築市場,其中以印度、中國和東南亞國家/地區為首。 生活水平提高、人均收入增加、工業化和基礎設施發展是這些國家建築活動增長的主要驅動力。
  • 此外,亞太地區的外國直接投資率很高,主要是在印度和中國,這是由於其製造成本低、勞動力廉價和客戶群廣泛。 該地區有利的經濟環境推動了對酒店、購物中心、摩天大樓和體育場館的需求。
  • 中國政府設立了一個 770 億美元的國家基礎設施投資基金,以振興基礎設施,以應對中國經濟增長停滯的局面。 2021年中國建築業產值為4.54萬億美元。
  • 另一方面,根據 Invest India 報告,在旨在改造 100 個城市的智慧城市任務和經濟適用房計劃的支持下,到 2025 年印度的建築業價值將達到 1.4 萬億美元。預計將達到
  • 在印度,從 2000 年 4 月到 2021 年 9 月,流入建設和開發部門(鄉鎮、住房、建築基礎設施、建設和開發項目)和建築(基礎設施)活動的外國直接投資各達 261 億美元。6000 萬美元和美國259.5 億美元。
  • 在中國和印度等國家/地區,由於政府的舉措和製造商的投資,藥品生產正在擴大。 預計將促進藥品生產研究市場的消費。
  • 醫藥行業是中國經濟持續發展的主要行業之一。 加入世界貿易組織(WTO)以來,中國醫藥工業發展迅速。 據國家統計局數據,2021年醫藥行業產值將達到5110億美元。
  • 印度在全球製藥領域佔有重要地位。 據印度品牌資產基金會稱,印度製藥業供應了全球 50% 以上的各種疫苗需求、40% 的美國仿製藥需求和 25% 的英國藥品總需求。 在全球範圍內,印度在藥品生產方面排名第三,在價值方面排名第十四。 國內製藥業擁有 3,000 家製藥公司和大約 10,500 台製造設備的網絡。
  • 因此,在這種發展的背景下,預計亞太地區對二氯甲烷的需求在預測期內將會增長。
二氯甲烷市場-IMG2

二氯甲烷行業概況

全球二氯甲烷市場本質上是分散的。 市場上的主要參與者包括 Nouryon、Olin Corporation、Oxy Chemical Corp.、Shin-Etsu Chemical、Tokuyama Corporation 等。

其他福利:

  • Excel 格式的市場預測 (ME) 表
  • 3 個月的分析師支持

內容

第一章介紹

  • 調查先決條件
  • 本次調查的範圍

第二章研究方法論

第 3 章執行摘要

第四章市場動態

  • 主持人
    • 油漆和塗料行業的需求增加
    • 其他司機
  • 約束因素
    • 二氯甲烷的有害影響
  • 行業價值鏈分析
  • 波特的五力分析
    • 供應商的議價能力
    • 消費者的議價能力
    • 新進入者的威脅
    • 替代品的威脅
    • 競爭程度

第 5 章市場細分

  • 用法
    • 脫漆劑
    • 醫藥
    • 化學處理
    • 聚苯乙烯泡沫塑料生產
    • 金屬清洗
    • 其他用途
  • 地區
    • 亞太地區
      • 中國
      • 印度
      • 日本
      • 韓國
      • 其他亞太地區
    • 北美
      • 美國
      • 加拿大
      • 墨西哥
    • 歐洲
      • 德國
      • 英國
      • 意大利
      • 法國
      • 其他歐洲
    • 南美洲
      • 巴西
      • 阿根廷
      • 其他南美洲
    • 中東和非洲
      • 沙特阿拉伯
      • 南非
      • 其他中東和非洲地區

第六章競爭格局

  • 併購、合資、合作、合同等。
  • 市場份額 (%)/排名分析
  • 主要公司採用的策略
  • 公司簡介
    • AGC Chemicals
    • Dow
    • Kem One
    • Nouryon
    • Olin Corporation
    • Oxy Chemical Corp
    • PJSC Khimprom
    • Shin-Etsu Chemical Co. Ltd
    • Spectrum Chemical Manufacturing Corp
    • Tokuyama Corporation

第七章市場機會與未來趨勢

簡介目錄
Product Code: 69255

The global market for methylene chloride is expected to register a CAGR of more than 4% during the forecast period. The market is expected to increase due to the rising demand from the paints and coatings industry.

Key Highlights

  • The increasing demand from the paints and coatings industry likely promotes market-studied growth.
  • However, owing to the harmful effects, methylene chloride is regulated across various significant countries.
  • Methylene chloride will likely remain mature in the refrigerant market, maintaining its demand in the coming years.
  • Asia-Pacific dominated the market and may continue its dominance during the forecast period.

Methylene Chloride Market Trends

Increasing Demand from Pharmaceutical Industry

  • Methylene chloride, also called Dichloromethane (DCM), is a solvent in pharmaceutical applications, mainly used to extract several compounds and produce antibiotics and vitamins. It is also used as a tablet-coating agent.
  • While the pharmaceutical industry had a mixed year globally, the underlying performance and outlook for the sector are positive. COVID-19 therapeutics boosted the growth of many companies, while most others remained relatively immune to some of the pandemic's effects.
  • New medications are being developed, approved, and marketed regularly, resulting in significant market growth. Other market growth drivers include the aging population, as seniors use more medicines per capita, and the prevalence and treatment of chronic diseases are increasing. Most countries' population profiles are becoming older. According to the World Health Organization (WHO), one in every six people will be over 60 by 2030.
  • The pharmaceutical industry is expected to reach about USD 1,700 billion by 2025, with an annual growth rate of 8%.
  • It is, moreover, owing to the growing middle class, aging, rising incomes, and increasing urbanization in countries such as the United States, China, and India.
  • The healthcare sector in the United States is one of the most advanced sectors in the country. According to the Pharmaceutical Research and Manufacturers Association (PhRMA), US firms conduct over half the world's R&D in pharmaceuticals and hold the intellectual property rights on most new medicines.
  • Therefore, the increasing pharmaceutical industry is expected to propel the methylene chloride demand during the forecast period.
Methylene Chloride Market - IMG1

Asia-Pacific Region to Dominate the Market

  • The Asia-Pacific region is expected to account for the largest market for methylene chloride during the forecast period.
  • Higher demand is expected from the major developing countries, such as China, India, Japan, and others.
  • Paints and coatings demand is increasing in the region. The automotive and construction industry contributes to a significant share in the consumption of paints and coatings.
  • Asia-Pacific includes the most prominent construction market globally, led by India, China, and various Southeast Asian countries. The main driving factors for the construction activities growth in these countries are increasing living standards, higher per capita income, industrialization, infrastructural development, etc.
  • Moreover, the Asia-Pacific region, with low manufacturing costs, cheap labor sourcing, and an extensive customer base, includes a substantial inflow of FDI, with India and China being the primary beneficiaries. The region's favorable economic climate boosted the demand for hotels, shopping malls, high-rise buildings, and stadiums.
  • The Chinese government built a state infrastructure investment fund worth USD 77 billion to revive its infrastructure to combat China's stunted economic growth. The construction output in China was valued at USD 4.54 trillion in 2021.
  • On the other hand, as per the Invest India Report, India's construction industry is heading to reach USD 1.4 trillion market size by 2025, supported by schemes about the smart city mission targeting the transformation of 100 cities and affordable housing.
  • In India, FDI in the construction development sector (townships, housing, built-up infrastructure, and construction development projects) and construction (infrastructure) activities amounted to USD 26.16 billion and USD 25.95 billion, respectively, between April 2000 and September 2021.
  • Pharmaceutical production in countries like China and India is growing due to government initiatives and manufacturers' investments in the sector. It is expected to boost the consumption of the market studied in pharmaceutical production.
  • The pharmaceutical sector is one of the key industries in China's continued economic development. From joining the World Trade Organization, China's pharmaceutical industry rapidly progressed. According to the National Bureau of Statistics, the pharmaceutical sector generated USD 511 billion in 2021.
  • India occupies an important position in the global pharmaceutical sector. According to the Indian Brand Equity Foundation, the Indian pharmaceutical sector supplies over 50% of the global demand for various vaccines, 40% of the US generic drug demand, and 25% of the total UK drug demand. Globally, India ranks 3rd in pharmaceutical production volume and 14th in value. The domestic pharmaceutical industry includes a network of 3,000 pharmaceutical companies and approximately 10,500 production units.
  • Hence, with such trends, the methylene chloride demand in the Asia-Pacific region is expected to grow during the forecast period.
Methylene Chloride Market - IMG2

Methylene Chloride Industry Overview

The global methylene chloride market is fragmented in nature. The major players in the market include Nouryon, Olin Corporation, Oxy Chemical Corp., Shin-Etsu Chemical Co. Ltd., and Tokuyama Corporation, among others.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Drivers
    • 4.1.1 Increasing Demand from Paints and Coatings Industry
    • 4.1.2 Other Drivers
  • 4.2 Restraints
    • 4.2.1 Harmful Effects of Methylene Chloride
  • 4.3 Industry Value Chain Analysis
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Bargaining Power of Suppliers
    • 4.4.2 Bargaining Power of Consumers
    • 4.4.3 Threat of New Entrants
    • 4.4.4 Threat of Substitute Products and Services
    • 4.4.5 Degree of Competition

5 MARKET SEGMENTATION (Market Size in Volume)

  • 5.1 Application
    • 5.1.1 Paint Remover
    • 5.1.2 Pharmaceuticals
    • 5.1.3 Chemical Processing
    • 5.1.4 Foam Manufacturing
    • 5.1.5 Metal Cleaning
    • 5.1.6 Other Applications
  • 5.2 Geography
    • 5.2.1 Asia-Pacific
      • 5.2.1.1 China
      • 5.2.1.2 India
      • 5.2.1.3 Japan
      • 5.2.1.4 South Korea
      • 5.2.1.5 Rest of Asia-Pacific
    • 5.2.2 North America
      • 5.2.2.1 United States
      • 5.2.2.2 Canada
      • 5.2.2.3 Mexico
    • 5.2.3 Europe
      • 5.2.3.1 Germany
      • 5.2.3.2 United Kingdom
      • 5.2.3.3 Italy
      • 5.2.3.4 France
      • 5.2.3.5 Rest of Europe
    • 5.2.4 South America
      • 5.2.4.1 Brazil
      • 5.2.4.2 Argentina
      • 5.2.4.3 Rest of South America
    • 5.2.5 Middle-East and Africa
      • 5.2.5.1 Saudi Arabia
      • 5.2.5.2 South Africa
      • 5.2.5.3 Rest of Middle-East and Africa

6 COMPETITIVE LANDSCAPE

  • 6.1 Mergers and Acquisitions, Joint Ventures, Collaborations, and Agreements
  • 6.2 Market Share (%)**/Ranking Analysis
  • 6.3 Strategies Adopted by Leading Players
  • 6.4 Company Profiles
    • 6.4.1 AGC Chemicals
    • 6.4.2 Dow
    • 6.4.3 Kem One
    • 6.4.4 Nouryon
    • 6.4.5 Olin Corporation
    • 6.4.6 Oxy Chemical Corp
    • 6.4.7 PJSC Khimprom
    • 6.4.8 Shin-Etsu Chemical Co. Ltd
    • 6.4.9 Spectrum Chemical Manufacturing Corp
    • 6.4.10 Tokuyama Corporation

7 MARKET OPPORTUNITIES AND FUTURE TRENDS